GLTO
Price
$4.51
Change
-$0.33 (-6.82%)
Updated
Feb 21 closing price
Capitalization
5.94M
VYNE
Price
$2.74
Change
+$0.04 (+1.48%)
Updated
Feb 21 closing price
Capitalization
40.42M
Ad is loading...

GLTO vs VYNE

Header iconGLTO vs VYNE Comparison
Open Charts GLTO vs VYNEBanner chart's image
Galecto
Price$4.51
Change-$0.33 (-6.82%)
Volume$11.06K
Capitalization5.94M
VYNE Therapeutics
Price$2.74
Change+$0.04 (+1.48%)
Volume$67.72K
Capitalization40.42M
GLTO vs VYNE Comparison Chart
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. VYNE commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and VYNE is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (GLTO: $4.82 vs. VYNE: $2.50)
Brand notoriety: GLTO and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 89% vs. VYNE: 43%
Market capitalization -- GLTO: $5.94M vs. VYNE: $40.42M
GLTO [@Biotechnology] is valued at $5.94M. VYNE’s [@Biotechnology] market capitalization is $40.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileVYNE’s FA Score has 1 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • VYNE’s FA Score: 1 green, 4 red.
According to our system of comparison, VYNE is a better buy in the long-term than GLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 2 TA indicator(s) are bullish while VYNE’s TA Score has 3 bullish TA indicator(s).

  • GLTO’s TA Score: 2 bullish, 5 bearish.
  • VYNE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, VYNE is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а +5.71% price change this week, while VYNE (@Biotechnology) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

GLTO is expected to report earnings on Nov 05, 2024.

VYNE is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYNE($40.4M) has a higher market cap than GLTO($5.94M). GLTO YTD gains are higher at: 3.551 vs. VYNE (-25.373). GLTO has higher annual earnings (EBITDA): -19.68M vs. VYNE (-37.7M). VYNE has more cash in the bank: 70.2M vs. GLTO (19.7M). GLTO has less debt than VYNE: GLTO (32K) vs VYNE (123K). VYNE has higher revenues than GLTO: VYNE (493K) vs GLTO (0).
GLTOVYNEGLTO / VYNE
Capitalization5.94M40.4M15%
EBITDA-19.68M-37.7M52%
Gain YTD3.551-25.373-14%
P/E RatioN/A0.83-
Revenue0493K-
Total Cash19.7M70.2M28%
Total Debt32K123K26%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOVYNE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
88%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
88%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
87%
View a ticker or compare two or three
Ad is loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been closely correlated with DSGN. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLTO jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+0.71%
DSGN - GLTO
83%
Closely correlated
+1.23%
TCRT - GLTO
56%
Loosely correlated
+0.62%
IMVT - GLTO
29%
Poorly correlated
+2.41%
VYNE - GLTO
28%
Poorly correlated
+1.21%
CRIS - GLTO
28%
Poorly correlated
-1.86%
More

VYNE and

Correlation & Price change

A.I.dvisor tells us that VYNE and AVXL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VYNE and AVXL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+1.21%
AVXL - VYNE
32%
Poorly correlated
+2.11%
ELVN - VYNE
31%
Poorly correlated
+0.65%
TRDA - VYNE
31%
Poorly correlated
-2.60%
VTGN - VYNE
31%
Poorly correlated
-1.18%
KOD - VYNE
31%
Poorly correlated
-2.09%
More